Quality assessment of acute viral bronchiolitis clinical practice guidelines

被引:10
作者
Rodriguez-Martinez, Carlos E. [1 ,2 ,3 ]
Sossa-Briceno, Monica P. [4 ]
Acuna-Cordero, Ranniery [5 ,6 ]
机构
[1] Univ Nacl Colombia, Sch Med, Dept Pediat, Ave Calle 127 20-78, Bogota 110101, Colombia
[2] Univ El Bosque, Sch Med, Dept Pediat Pulmonol & Pediat Crit Care Med, Bogota, Colombia
[3] Mil Hosp Colombia, Res Unit, Bogota, Colombia
[4] Univ Nacl Colombia, Sch Med, Dept Internal Med, Bogota, Colombia
[5] Hosp Militar Cent, Dept Pediat Pulmonol, Bogota, Colombia
[6] Univ Militar Nueva Granada, Sch Med, Dept Pediat, Bogota, Colombia
关键词
bronchiolitis; clinical practice guideline; health care quality assessment; MANAGEMENT; PREVENTION; ADHERENCE; DIAGNOSIS; DECISION;
D O I
10.1111/jep.12446
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Rationale, aims and objectivesRecently, in an attempt to reduce variability in clinical practice and produce better results for patients, several clinical practice guidelines (CPGs) for the appropriate diagnosis and management of bronchiolitis in infants have been developed. However, the quality of available CPGs for bronchiolitis management has not yet been systematically evaluated. The aim of this study was to assess the quality of acute viral bronchiolitis CPGs. MethodWe performed a systematic and exhaustive search of CPGs on bronchiolitis published from 2000 to 2014. Three independent appraisers assessed the quality of the CPGs using the Appraisal of Guidelines Research and Evaluation (AGREE) II instrument. A standardized score was calculated for each of the six domains, and the CPGS were rated as recommended, recommended with modifications, or not recommended. ResultsSix CPGs published between the years 2000 and 2014 were selected from a total of 111 citations. There was substantial agreement among reviewers (ICC: 0.75; 95% CI, 0.61-0.89). The domains that scored the highest were scope and purpose', with a mean value of 92.1% (range: 77.8-100%), and clarity of presentation' [83.3% (69.4-91.7%)]. Those that scored the lowest were applicability' [44.3% (8.3-77.1%)], and stakeholder involvement' [66.7% (47.2-94.4%)]. Three CPGS were evaluated as being recommended with modifications, and only two were recommended for use in clinical practice. ConclusionsAvailable bronchiolitis CPGs vary in quality, and the findings of the present study are useful for identifying aspects or domains where there is room for improvement in future CPGs.
引用
收藏
页码:37 / 43
页数:7
相关论文
共 32 条
[1]   Quality Assessment of Asthma Clinical Practice Guidelines A Systematic Appraisal [J].
Acuna-Izcaray, Agustin ;
Sanchez-Angarita, Efrain ;
Plaza, Vicente ;
Rodrigo, Gustavo ;
Montes de Oca, Maria ;
Gich, Ignasi ;
Bonfill, Xavier ;
Alonso-Coello, Pablo .
CHEST, 2013, 144 (02) :390-397
[2]   The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies [J].
Alonso-Coello, Pablo ;
Irfan, Affan ;
Sola, Ivan ;
Gich, Ignasi ;
Delgado-Noguera, Mario ;
Rigau, David ;
Tort, Sera ;
Bonfill, Xavier ;
Burgers, Jako ;
Schunemann, Holger .
QUALITY & SAFETY IN HEALTH CARE, 2010, 19 (06) :e58
[3]  
[Anonymous], 2006, NATL CLIN GUIDELINE
[4]  
[Anonymous], 2009, The AGREE II Instrument
[5]  
*AS COL NEUM PED, 2013, GUIA PRACT CLIN GPC
[6]  
*BRONCH GUID TEAM, 2010, BRONCH PED EV BAS CA, P1
[7]   AGREE II: advancing guideline development, reporting and evaluation in health care [J].
Brouwers, Melissa C. ;
Kho, Michelle E. ;
Browman, George P. ;
Burgers, Jako S. ;
Cluzeau, Francoise ;
Feder, Gene ;
Fervers, Beatrice ;
Graham, Ian D. ;
Grimshaw, Jeremy ;
Hanna, Steven E. ;
Littlejohns, Peter ;
Makarski, Julie ;
Zitzelsberger, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842
[8]   Variation in inpatient diagnostic testing and management of bronchiolitis [J].
Christakis, DA ;
Cowan, CA ;
Garrison, MM ;
Molteni, R ;
Marcuse, E ;
Zerr, DM .
PEDIATRICS, 2005, 115 (04) :878-884
[9]  
*COL, 2014, GUIA PRACT CLIN EV R
[10]   BRONCHIOLITIS - ORIGINS AND OPTIMAL MANAGEMENT [J].
EVERARD, ML .
DRUGS, 1995, 49 (06) :885-896